These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 3139891

  • 1. Effects of radioligand oxidation and ascorbate-induced lipid peroxidation on serotonin-1 receptor assay: use of ascorbate and ethylenediamine tetraacetic acid buffers to prevent (3H)-5-HT binding artifacts.
    May PC, Morgan DG, Salo D, Goss JR, Finch CE.
    J Neurosci Res; 1988; 20(2):257-62. PubMed ID: 3139891
    [Abstract] [Full Text] [Related]

  • 2. Ascorbic acid prevents nonreceptor "specific" binding of [3H]-5-hydroxytryptamine to bovine cerebral cortex membranes.
    Hamblin MW, Adriaenssens PI, Ariani K, Cawthon RM, Stratford CA, Tan GL, Ciaranello RD.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):701-11. PubMed ID: 3559968
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation.
    Ebersole BJ, Molinoff PB.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):337-44. PubMed ID: 1833526
    [Abstract] [Full Text] [Related]

  • 4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 5. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
    Sills MA, Wolfe BB, Frazer A.
    Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
    [Abstract] [Full Text] [Related]

  • 6. Ascorbate induced lipid peroxidation results in loss of receptor binding in tris, but not in phosphate, buffer. Implications for the involvement of metal ions.
    Abe K, Kogure K, Arai H, Nakano M.
    Biochem Int; 1985 Sep; 11(3):341-8. PubMed ID: 3933512
    [Abstract] [Full Text] [Related]

  • 7. Dual effects of ascorbate on serotonin and spiperone binding in rat cortical membranes.
    Muakkassah-Kelly SF, Andresen JW, Shih JC, Hochstein P.
    J Neurochem; 1983 Nov; 41(5):1429-39. PubMed ID: 6413657
    [Abstract] [Full Text] [Related]

  • 8. Elimination of ascorbic acid-induced membrane lipid peroxidation and serotonin receptor loss by Trolox-C, a water soluble analogue of vitamin E.
    Britt SG, Chiu VW, Redpath GT, VandenBerg SR.
    J Recept Res; 1992 Nov; 12(2):181-200. PubMed ID: 1583621
    [Abstract] [Full Text] [Related]

  • 9. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, Van Gompel P, Wouters R, Lesage AS.
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [Abstract] [Full Text] [Related]

  • 10. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    Andorn AC, Bacon BR, Nguyen-Hunh AT, Parlato SJ, Stitts JA.
    Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
    [Abstract] [Full Text] [Related]

  • 11. Necessity of ascorbic acid in the radioligand binding assay for [3H]5-hydroxytryptamine.
    Andresen JW, Shih JC.
    Neuropharmacology; 1986 Aug; 25(8):869-75. PubMed ID: 3774116
    [Abstract] [Full Text] [Related]

  • 12. Artifactual high-affinity and saturable binding of [3H]5-hydroxytryptamine induced by radioligand oxidation.
    Peroutka SJ, Ison PJ, Liu DU, Barrett RW.
    J Neurochem; 1986 Jul; 47(1):38-45. PubMed ID: 3711910
    [Abstract] [Full Text] [Related]

  • 13. Studies on the stability of 3H-dopamine, 3H-apomorphine and 3H-ADTN: effects of sodium ascorbate and EDTA.
    Cabbat FS, Manzino L, Heikkila RE.
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):333-43. PubMed ID: 3922020
    [Abstract] [Full Text] [Related]

  • 14. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D, Neijt HC.
    Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
    [Abstract] [Full Text] [Related]

  • 15. Possible relationship between changes in [3H]DA uptake and autoxidation in rat striatal slices.
    Page G, Barrier L, Morel P, Schulzberg M, Piriou A, Huguet F.
    Exp Neurol; 1998 Jul; 152(1):88-94. PubMed ID: 9682015
    [Abstract] [Full Text] [Related]

  • 16. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M, Kiel S, Bönisch H, Kostanian A, Göthert M.
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [Abstract] [Full Text] [Related]

  • 17. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
    Rogines-Velo MP, Pelorosso FG, Zold CL, Nowak W, Pesce GO, Sardi SP, Brodsky PT, Rothlin RP.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
    [Abstract] [Full Text] [Related]

  • 18. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA, Tan GL, Hamblin MW, Ciaranello RD.
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [Abstract] [Full Text] [Related]

  • 19. Role of lipids in receptor mediated signal transduction.
    Banerjee P.
    Indian J Biochem Biophys; 1993 Dec; 30(6):358-69. PubMed ID: 8005619
    [Abstract] [Full Text] [Related]

  • 20. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.
    Thomas SR, Davies MJ, Stocker R.
    Chem Res Toxicol; 1998 May; 11(5):484-94. PubMed ID: 9585479
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.